GAMIDA CELL LTD. WARRANT Dated «Closing_Date» (the “Closing”) To purchase «Number_of_F2_Shares_underlying_Warrants» Series F-2 Preferred Shares (as defined below) (subject to adjustment hereunder) of Gamida Cell Ltd. (the “Company”) at a per share...Warrant Agreement • September 28th, 2018 • Gamida Cell Ltd. • Biological products, (no disgnostic substances)
Y = the number of Warrant Shares otherwise purchasable upon exercise in full of this Warrant (or such lesser number of shares as Holder may designate in case of a partial exercise of this Warrant) as of the time the net issue election is made pursuant to this Section 1.5;
MANUFACTURING SERVICES AGREEMENTManufacturing Services Agreement • September 28th, 2018 • Gamida Cell Ltd. • Biological products, (no disgnostic substances) • New York
This Manufacturing Services Agreement (the “Agreement”) is made as of February 8, 2016, (the “Effective Date”) between Lonza Walkersville, Inc., a Delaware corporation having its principal place of business at 8830 Biggs Ford Road, Walkersville, Maryland 21793 (“LWI”), and Gamida Cell Ltd., an Israeli corporation (“CLIENT”) (each of LWI and CLIENT, a “Party” and, collectively, the “Parties”).
AMENDMENT NO. 2 TO MANUFACTURING SERVICES AGREEMENTManufacturing Services Agreement • September 28th, 2018 • Gamida Cell Ltd. • Biological products, (no disgnostic substances)
This Amendment No. 2 (the “Amendment”) is made as of May ___, 2016 (“to that certain Manufacturing Services Agreement by and between Gamida Cell Ltd. (“Client”) and Lonza Walkersville, Inc. (“Lonza”) effective as of February 8, 2016 (as amended, the “Agreement”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Agreement.
AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • September 28th, 2018 • Gamida Cell Ltd. • Biological products, (no disgnostic substances)
THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT is made as of July 3, 2017, by and among Gamida Cell Ltd., an Israeli company (the “Company”), and the Investors listed on Schedule A hereto (including any additional Investor that becomes a party to this Agreement following the date hereof in accordance with Section 5.9 hereof), each of which is referred to in this Agreement as an “Investor”.
Unprotected Lease AgreementLease Agreement • September 28th, 2018 • Gamida Cell Ltd. • Biological products, (no disgnostic substances)
Between: Y.D.B Investments Ltd., Company Registration No. 514479518 By Mr. Yoram Bar-On, ID. No. 057315616, the authorized signatory on behalf of the Company Of 1 Mavo Sivan St., Kiryat Gat (Hereinafter: "the Lessor") The first party;
Unprotected Rental Contract Drafted and signed in Jerusalem on March 14, 2000 - between -Rental Contract • September 28th, 2018 • Gamida Cell Ltd. • Biological products, (no disgnostic substances)
Whereas: The Lessor owns the rights to register as a lessee for a capitalized lease in a building that is under construction at 5 Nachum Hefzadi Street, Givat Shaul Gimmel, Jerusalem, known as part of Parcels 57 and 61 in Bloc 30260, Plot No. 5 according to Detailed Plan No. 4286 (hereinafter – “the Plot”), constituting a light industry building, for commerce and offices and known as Ofer House (hereinafter – “the Building”), while by the Building the Lessor intends to build an additional building for a similar purpose, and
